DR. DANY A OBEID MD NPI 1841336310

NPI Details

DR. Dany A Obeid, MD is a pulmonary disease internal medicine in Daytona Beach, FL with 26 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. DR. Dany A Obeid, MD NPI is 1841336310. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

305 MEMORIAL MEDICAL PKWY
SUITE 501
DAYTONA BEACH, FL
ZIP 32117-168
Phone: (386) 615-0900
Fax: (386) 615-0902

The NPI 1841336310 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Evaluation of use of breathing device (HCPCS:94664)
• Test for exercise-induced lung stress (HCPCS:94618)
• Sleep study including heart rate, breathing, and sleep time (HCPCS:95800)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Irrigation and suction of lung airways to obtain cells using an endoscope (HCPCS:31624)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)

The enumeration date for this NPI number is 1/30/2007 and was last updated on 1/19/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.